The price is accelerating after sales forecasts for Q4 were raised.
Clear compression with a retest of the previous low, the price is now heading toward the blue resistance around $170, and in case of a breakout, could continue toward $208.
The medical sector has been largely overlooked in recent years in favor of AI stocks, but a renewed interest in 2026 is very likely.
Clear compression with a retest of the previous low, the price is now heading toward the blue resistance around $170, and in case of a breakout, could continue toward $208.
The medical sector has been largely overlooked in recent years in favor of AI stocks, but a renewed interest in 2026 is very likely.
Catatan
Ready for a breakoutCatatan
breakout confirmed
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.